More PRNewswire
View Older Stories View Newer Stories-
JA Solar Leads the Post‑Cycle PV Market with Dual‑Technology Breakthroughs and Integrated Solutions
-
Blaize and Winmate Bring Rugged Edge AI from the U.S. to the Global Stage at COMPUTEX 2026, Advancing Joint Mission-Critical and Industrial Solutions
-
A new era for retail buying; London-based retail technology company Handshake raises $3.2M to scale AI-native platform
-
XPENG Announces Vehicle Delivery Results for May 2026
-
Landis+Gyr Capital Markets Day 2026
-
Bakery China 2026 Concludes Successfully, Advancing Global Integration and Innovation in the Bakery Industry
-
Millennium Premier Hotel New York Times Square Reopens June 1 Following Comprehensive Renovation
-
HONEYWELL UNVEILS NEW BRANDS EFFECTIVE POST SPIN-OFF: HONEYWELL TECHNOLOGIES AND HONEYWELL AEROSPACE
-
ALZHEIMER'S & BRAIN AWARENESS MONTH: TAKE CHARGE OF YOUR BRAIN HEALTH
-
Global Fintech Revenues Surpass Half a Trillion Dollars, Growing Four Times Faster Than Traditional Banks
-
IREN and BE Networks Accelerate Deployment of Large-Scale AI Factory with NVIDIA DSX Air
-
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
-
Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting
-
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)
-
Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou
-
TrendAI™ Launches Inception Program to Power the Next Wave of Secure AI Innovation
-
Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers
-
ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
-
BC.GAME Taps Into Football Fever With Pinball Striker 20000X
-
IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications
-
Changingtek Robotics Launches High-Precision Tactile Sensing Data Collection Hand, Uhand
-
LG Display to showcase world's largest Gaming OLED lineup in Taiwan
-
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept
-
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
-
MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026
-
AMD Bundles Carbice Ice Pad with Ryzen™ 7 5800X3D
-
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherap
-
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
-
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
-
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Builders
-
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
-
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026
-
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026
-
Scripps Pulls 54 Local Stations from DIRECTV After Seeking Record Retransmission Consent Rates
-
Web3 Has No Safe AI. DMind AI Just Quantified the Gap -- and KDD 2026 Made It Official.
-
Cango Inc. Reports First Quarter 2026 Unaudited Financial Results
-
Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
-
Mazda Announces New Zinc Green Color
-
Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
-
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
-
Kulani Kinis Makes Miami Swim Week Debut with "Endless" Runway Experience and SOJOS Eyewear Collaboration
-
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
-
CPKC to maintain rail operations across Canada during IBEW strike
-
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
-
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradi
-
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
-
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annua
-
Miami Retirement Summit 2026 Returns to The Biltmore Featuring Coral Gables Mayor Vince Lago
-
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders
